(Q33933118)

30 July 2017

Selective boron drug delivery to brain tumors for boron neutron capture therapy (English)

1 reference

30 July 2017

1 reference

0 references

1 reference

Lu DR

1

1 reference

30 July 2017

Mehta SC

series ordinal

2

1 reference

30 July 2017

Chen W

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

Advanced Drug Delivery Reviews

30 July 2017

1 reference

30 July 2017

26

1 reference

30 July 2017

2-3

1 reference

30 July 2017

231-247

1 reference

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Selection bias, survival, and brachytherapy for glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Pathological study of eight patients with glioblastoma multiforme treated by neutron-capture therapy using boron 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Boron neutron capture therapy of a rat glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Boron neutron capture therapy of cerebral gliomas. II. Utilization of the blood-brain barrier and tumor-specific antigens for the selective concentration of boron in gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Boron neutron capture therapy for cancer. Realities and prospects.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Targeted drug delivery for boron neutron capture therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Transferrin receptor on endothelium of brain capillaries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron Compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Present status and perspectives of boron neutron capture therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Borocaptate sodium: a potential boron delivery compound for boron neutron capture therapy evaluated in dogs with spontaneous intracranial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

A method for calculating the absorbed dose near interface from 10B(n, alpha)7Li reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

The effect of geometry on capillary wall dose for boron neutron capture therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Boron uptake in melanoma, cerebrum and blood from Na2B12H11SH and Na4B24H22S2 administered to mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Interspecies pharmacokinetic scaling of BSH in mice, rats, rabbits, and humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Dose-dependent disposition kinetics and tissue accumulation of boron after intravenous injections of sodium mercaptoundecahydrododecaborate in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Boronation of antibodies with mercaptoundecahydro-closo-dodecaborate(2-) anion for potential use in boron neutron capture therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Toxicities of Na2B12H11SH and Na4B24H22S2 in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Boronated metalloporphyrins: a novel approach to the diagnosis and treatment of cancer using contrast-enhanced MR imaging and neutron capture therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Specific killing effect of 10B1-para-boronophenylalanine in thermal neutron capture therapy of malignant melanoma: in vitro radiobiological evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

The pharmacokinetics of p-Boronophenylalanine.fructose in human patients with glioma and metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Improved bioavailability of para-boronophenylalanine by cyclodextrin complexation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Pharmacokinetics of 5-carboranyl-2'-deoxyuridine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Synthesis of carboranes containing nucleoside bases. Unexpectedly high cytostatic and cytocidal toxicity towards cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Neurotoxicity of vincristine after the osmotic opening of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Osmotic Blood-Brain Barrier Modification and Combination Chemotherapy: Concurrent Tumor Regression in Areas of Barrier Opening and Progression in Brain Regions Distant to Barrier Opening

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Selective blood-tumor barrier disruption by leukotrienes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

γ-Glutamyltranspeptidase induction mediated by glial foot process-to endothelium contact in co-culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Bacterial meningitis: pathogenesis, pathophysiology, and progress

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Penetration of the blood-brain barrier: enhancement of drug delivery and imaging by bacterial glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo--a new possibility in boron neutron capture therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

The role of minocycline in the treatment of intracranial 9L glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Intralesional radioimmunotherapy of malignant gliomas. An effective treatment in recurrent tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Novel carboranyl amino acids and peptides: reagents for antibody modification and subsequent neutron-capture studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Model studies directed toward the boron neutron-capture therapy of cancer: boron delivery to murine tumors with liposomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Na3[B20H17NH3]: synthesis and liposomal delivery to murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Accumulation of 99mTc-low-density lipoprotein in human malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900037-9

7 January 2021

10.1016/S0169-409X(97)00037-9

Identifiers

DOI

1 reference

30 July 2017

1 reference